Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture

69Citations
Citations of this article
149Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Insulin-producing cells (IPCs) derived from human pluripotent stem cells (hPSCs) may be useful in cell therapy and drug discovery for diabetes. Here, we examined various growth factors and small molecules including those previously reported to develop a robust differentiation method for induction of mature IPCs from hPSCs. We established a protocol that induced PDX1-positive pancreatic progenitor cells at high efficiency, and further induced mature IPCs by treatment with forskolin, dexamethasone, Alk5 inhibitor II and nicotinamide in 3D culture. The cells that differentiated into INSULIN-positive and C-PEPTIDE-positive cells secreted insulin in response to glucose stimulation, indicating a functional IPC phenotype. We also found that this method was applicable to different types of hPSCs.

Cite

CITATION STYLE

APA

Takeuchi, H., Nakatsuji, N., & Suemori, H. (2014). Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture. Scientific Reports, 4. https://doi.org/10.1038/srep04488

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free